Access to GLP-1 medications associated with a lower risk of colorectal cancer in people with type 2 diabetes: JAMA.

Published Date: 11 Dec 2023

USA: Glucagon-like peptide 1 (GLP-1) was found to be more effective in reducing the risk of colorectal cancer (CRC) in a nationwide cohort study.

Read Full News

Latest News



Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

automated, precise reporting for clonality testing using NGS.

2.

FDA Approves First Menin Inhibitor for Acute Leukemia

3.

Exercise could ease symptoms for people with chronic lymphocytic leukemia, support and guidance are lacking: Study

4.

Antitumor mRNA-based vaccines show potential against gastric cancer metastasis

5.

Healthy weight loss could lower your odds for cancer


© Copyright 2025 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot